A detailed history of Jacob Asset Management Of New York LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Jacob Asset Management Of New York LLC holds 168,730 shares of DMAC stock, worth $742,412. This represents 0.62% of its overall portfolio holdings.

Number of Shares
168,730
Previous 198,730 15.1%
Holding current value
$742,412
Previous $858,000 49.3%
% of portfolio
0.62%
Previous 0.97%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

SELL
$2.56 - $4.4 $76,800 - $132,000
-30,000 Reduced 15.1%
168,730 $435,000
Q2 2023

Aug 10, 2023

SELL
$1.53 - $4.4 $53,550 - $154,000
-35,000 Reduced 14.97%
198,730 $858,000
Q4 2022

Feb 14, 2023

SELL
$1.13 - $1.62 $5,390 - $7,727
-4,770 Reduced 2.0%
233,730 $369,000
Q2 2022

Aug 11, 2022

SELL
$1.86 - $2.62 $49,290 - $69,430
-26,500 Reduced 10.0%
238,500 $482,000
Q1 2022

May 12, 2022

SELL
$2.29 - $3.88 $22,900 - $38,800
-10,000 Reduced 3.64%
265,000 $663,000
Q2 2021

Oct 04, 2021

BUY
$4.45 - $9.91 $400,500 - $891,900
90,000 Added 48.65%
275,000 $1.22 Million
Q1 2021

Oct 04, 2021

BUY
$7.76 - $10.43 $349,200 - $469,350
45,000 Added 32.14%
185,000 $1.69 Million
Q4 2020

Oct 04, 2021

BUY
$4.13 - $10.14 $578,200 - $1.42 Million
140,000 New
140,000 $1.42 Million

Others Institutions Holding DMAC

About DiaMedica Therapeutics Inc.


  • Ticker DMAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,443,100
  • Market Cap $116M
  • Description
  • DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...
More about DMAC
Track This Portfolio

Track Jacob Asset Management Of New York LLC Portfolio

Follow Jacob Asset Management Of New York LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.